ArticleBritish journal of cancer2023

Pamiparib in combination with tislelizumab in patients with advanced solid tumours: results from the dose-expansion stage of a multicentre, open-label, phase I trial.

Michael Friedlander et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.